Alethia Young

Stock Analyst at Cantor Fitzgerald

(3.72)
# 790
Out of 4,722 analysts
144
Total ratings
55.65%
Success rate
32.31%
Average return

Stocks Rated by Alethia Young

Arcus Biosciences
Jul 5, 2024
Reiterates: Overweight
Price Target: n/a
Current: $15.16
Upside: -
Arrowhead Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $19.95
Upside: -
Regeneron Pharmaceuticals
Oct 16, 2023
Maintains: Neutral
Price Target: $800$850
Current: $740.29
Upside: +14.82%
ALX Oncology Holdings
Sep 12, 2023
Reiterates: Overweight
Price Target: $18
Current: $1.86
Upside: +867.74%
Curis
Sep 7, 2023
Reiterates: Overweight
Price Target: $60
Current: $3.52
Upside: +1,604.55%
Eledon Pharmaceuticals
Aug 22, 2023
Reiterates: Overweight
Price Target: $9
Current: $4.33
Upside: +108.09%
Verastem
Jul 6, 2023
Reiterates: Overweight
Price Target: $34
Current: $6.14
Upside: +453.75%
Biogen
Oct 15, 2021
Maintains: Neutral
Price Target: $427$327
Current: $151.69
Upside: +115.57%
Adverum Biotechnologies
Jul 23, 2021
Downgrades: Neutral
Price Target: $230$30
Current: $4.53
Upside: +562.25%
RAPT Therapeutics
Jun 14, 2021
Maintains: Overweight
Price Target: $51$71
Current: $1.45
Upside: +4,796.55%
Maintains: Overweight
Price Target: $285$281
Current: $411.96
Upside: -31.79%
Initiates: Overweight
Price Target: $8
Current: $1.81
Upside: +343.21%
Maintains: Overweight
Price Target: $86$98
Current: $1.67
Upside: +5,785.89%
Maintains: Overweight
Price Target: $280$295
Current: $262.98
Upside: +12.18%
Reiterates: Overweight
Price Target: $84$86
Current: $89.41
Upside: -3.81%
Maintains: Overweight
Price Target: $30$48
Current: $28.70
Upside: +67.25%
Initiates: Overweight
Price Target: $30
Current: $14.50
Upside: +106.90%
Maintains: Overweight
Price Target: $70$72
Current: $35.85
Upside: +100.86%
Assumes: Overweight
Price Target: $5
Current: $2.12
Upside: +135.99%
Maintains: Neutral
Price Target: $83$100
Current: $73.32
Upside: +36.39%
Reiterates: Overweight
Price Target: $28$24
Current: $0.53
Upside: +4,402.81%
Reiterates: Overweight
Price Target: $185$201
Current: $134.41
Upside: +49.54%
Reiterates: Overweight
Price Target: $86$85
Current: $44.84
Upside: +89.56%
Maintains: Overweight
Price Target: $30$32
Current: $8.37
Upside: +282.32%
Reiterates: Overweight
Price Target: $211$217
Current: $126.24
Upside: +71.89%
Maintains: Neutral
Price Target: $75$48
Current: $14.50
Upside: +231.03%
Downgrades: Underperform
Price Target: n/a
Current: $17.49
Upside: -
Maintains: Outperform
Price Target: $151$154
Current: $239.56
Upside: -35.72%
Maintains: Outperform
Price Target: $113$116
Current: $68.52
Upside: +69.29%
Maintains: Outperform
Price Target: $147$106
Current: $3.56
Upside: +2,881.72%
Maintains: Outperform
Price Target: $24$28
Current: $12.00
Upside: +133.33%
Maintains: Neutral
Price Target: $85$82
Current: $183.98
Upside: -55.43%
Initiates: Underperform
Price Target: n/a
Current: $363.12
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $2.79
Upside: -